カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のパクリタキセル薬物市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Paclitaxel Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19506）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19506
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のパクリタキセル薬物市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

パクリタキセル薬物市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のパクリタキセル薬物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

パクリタキセル薬物市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・30mg、100mg

用途別セグメントは次のように区分されます。
・病院、ドラッグストア

世界のパクリタキセル薬物市場の主要な市場プレーヤーは以下のとおりです。
・Luye Pharma、CSPC Company、Celgene、Jiangsu Hengrui、Bristol-Myers Squibb、Pfizer、Teva、Mylan、Novartis

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、パクリタキセル薬物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なパクリタキセル薬物メーカーの企業概要、2019年～2022年までのパクリタキセル薬物の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なパクリタキセル薬物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別パクリタキセル薬物の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのパクリタキセル薬物の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのパクリタキセル薬物市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびパクリタキセル薬物の産業チェーンを掲載しています。
・第13、14、15章では、パクリタキセル薬物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- パクリタキセル薬物の概要
- 種類別分析（2017年vs2021年vs2028年）：30mg、100mg
- 用途別分析（2017年vs2021年vs2028年）：病院、ドラッグストア
- 世界のパクリタキセル薬物市場規模・予測
- 世界のパクリタキセル薬物生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Luye Pharma、CSPC Company、Celgene、Jiangsu Hengrui、Bristol-Myers Squibb、Pfizer、Teva、Mylan、Novartis
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：30mg、100mg
・用途別分析2017年-2028年：病院、ドラッグストア
・パクリタキセル薬物の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・パクリタキセル薬物のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・パクリタキセル薬物のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・パクリタキセル薬物の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・パクリタキセル薬物の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Paclitaxel Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Paclitaxel Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Paclitaxel Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 30mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Paclitaxel Drug include Luye Pharma, CSPC Company, Celgene, Jiangsu Hengrui, and Bristol-Myers Squibb, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Paclitaxel Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
30mg
100mg
Market segment by Application can be divided into
Hospital
Drugs Store
The key market players for global Paclitaxel Drug market are listed below:
Luye Pharma
CSPC Company
Celgene
Jiangsu Hengrui
Bristol-Myers Squibb
Pfizer
Teva
Mylan
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paclitaxel Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Paclitaxel Drug, with price, sales, revenue and global market share of Paclitaxel Drug from 2019 to 2022.
Chapter 3, the Paclitaxel Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Paclitaxel Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Paclitaxel Drug.
Chapter 13, 14, and 15, to describe Paclitaxel Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Paclitaxel Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Paclitaxel Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 30mg
1.2.3 100mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Paclitaxel Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Global Paclitaxel Drug Market Size & Forecast
1.4.1 Global Paclitaxel Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Paclitaxel Drug Sales in Volume (2017-2028)
1.4.3 Global Paclitaxel Drug Price (2017-2028)
1.5 Global Paclitaxel Drug Production Capacity Analysis
1.5.1 Global Paclitaxel Drug Total Production Capacity (2017-2028)
1.5.2 Global Paclitaxel Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Paclitaxel Drug Market Drivers
1.6.2 Paclitaxel Drug Market Restraints
1.6.3 Paclitaxel Drug Trends Analysis
2 Manufacturers Profiles
2.1 Luye Pharma
2.1.1 Luye Pharma Details
2.1.2 Luye Pharma Major Business
2.1.3 Luye Pharma Paclitaxel Drug Product and Services
2.1.4 Luye Pharma Paclitaxel Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSPC Company
2.2.1 CSPC Company Details
2.2.2 CSPC Company Major Business
2.2.3 CSPC Company Paclitaxel Drug Product and Services
2.2.4 CSPC Company Paclitaxel Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Paclitaxel Drug Product and Services
2.3.4 Celgene Paclitaxel Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Jiangsu Hengrui
2.4.1 Jiangsu Hengrui Details
2.4.2 Jiangsu Hengrui Major Business
2.4.3 Jiangsu Hengrui Paclitaxel Drug Product and Services
2.4.4 Jiangsu Hengrui Paclitaxel Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Paclitaxel Drug Product and Services
2.5.4 Bristol-Myers Squibb Paclitaxel Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Paclitaxel Drug Product and Services
2.6.4 Pfizer Paclitaxel Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva Paclitaxel Drug Product and Services
2.7.4 Teva Paclitaxel Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Paclitaxel Drug Product and Services
2.8.4 Mylan Paclitaxel Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Paclitaxel Drug Product and Services
2.9.4 Novartis Paclitaxel Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Paclitaxel Drug Breakdown Data by Manufacturer
3.1 Global Paclitaxel Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Paclitaxel Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Paclitaxel Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Paclitaxel Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Paclitaxel Drug Manufacturer Market Share in 2021
3.5 Global Paclitaxel Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Paclitaxel Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Paclitaxel Drug Market Size by Region
4.1.1 Global Paclitaxel Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Paclitaxel Drug Revenue by Region (2017-2028)
4.2 North America Paclitaxel Drug Revenue (2017-2028)
4.3 Europe Paclitaxel Drug Revenue (2017-2028)
4.4 Asia-Pacific Paclitaxel Drug Revenue (2017-2028)
4.5 South America Paclitaxel Drug Revenue (2017-2028)
4.6 Middle East and Africa Paclitaxel Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Paclitaxel Drug Sales in Volume by Type (2017-2028)
5.2 Global Paclitaxel Drug Revenue by Type (2017-2028)
5.3 Global Paclitaxel Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Paclitaxel Drug Sales in Volume by Application (2017-2028)
6.2 Global Paclitaxel Drug Revenue by Application (2017-2028)
6.3 Global Paclitaxel Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Paclitaxel Drug Sales by Type (2017-2028)
7.2 North America Paclitaxel Drug Sales by Application (2017-2028)
7.3 North America Paclitaxel Drug Market Size by Country
7.3.1 North America Paclitaxel Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Paclitaxel Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Paclitaxel Drug Sales by Type (2017-2028)
8.2 Europe Paclitaxel Drug Sales by Application (2017-2028)
8.3 Europe Paclitaxel Drug Market Size by Country
8.3.1 Europe Paclitaxel Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Paclitaxel Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Paclitaxel Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Paclitaxel Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Paclitaxel Drug Market Size by Region
9.3.1 Asia-Pacific Paclitaxel Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Paclitaxel Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Paclitaxel Drug Sales by Type (2017-2028)
10.2 South America Paclitaxel Drug Sales by Application (2017-2028)
10.3 South America Paclitaxel Drug Market Size by Country
10.3.1 South America Paclitaxel Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Paclitaxel Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Paclitaxel Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Paclitaxel Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Paclitaxel Drug Market Size by Country
11.3.1 Middle East & Africa Paclitaxel Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Paclitaxel Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Paclitaxel Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Paclitaxel Drug
12.3 Paclitaxel Drug Production Process
12.4 Paclitaxel Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Paclitaxel Drug Typical Distributors
13.3 Paclitaxel Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Paclitaxel Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Paclitaxel Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Luye Pharma Major Business
Table 5. Luye Pharma Paclitaxel Drug Product and Services
Table 6. Luye Pharma Paclitaxel Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CSPC Company Basic Information, Manufacturing Base and Competitors
Table 8. CSPC Company Major Business
Table 9. CSPC Company Paclitaxel Drug Product and Services
Table 10. CSPC Company Paclitaxel Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Celgene Basic Information, Manufacturing Base and Competitors
Table 12. Celgene Major Business
Table 13. Celgene Paclitaxel Drug Product and Services
Table 14. Celgene Paclitaxel Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 16. Jiangsu Hengrui Major Business
Table 17. Jiangsu Hengrui Paclitaxel Drug Product and Services
Table 18. Jiangsu Hengrui Paclitaxel Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Major Business
Table 21. Bristol-Myers Squibb Paclitaxel Drug Product and Services
Table 22. Bristol-Myers Squibb Paclitaxel Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Paclitaxel Drug Product and Services
Table 26. Pfizer Paclitaxel Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Teva Basic Information, Manufacturing Base and Competitors
Table 28. Teva Major Business
Table 29. Teva Paclitaxel Drug Product and Services
Table 30. Teva Paclitaxel Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Paclitaxel Drug Product and Services
Table 34. Mylan Paclitaxel Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Novartis Basic Information, Manufacturing Base and Competitors
Table 36. Novartis Major Business
Table 37. Novartis Paclitaxel Drug Product and Services
Table 38. Novartis Paclitaxel Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Paclitaxel Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Paclitaxel Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Paclitaxel Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Paclitaxel Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Paclitaxel Drug Production Site of Key Manufacturer
Table 44. Paclitaxel Drug New Entrant and Capacity Expansion Plans
Table 45. Paclitaxel Drug Mergers & Acquisitions in the Past Five Years
Table 46. Global Paclitaxel Drug Sales by Region (2017-2022) & (K Units)
Table 47. Global Paclitaxel Drug Sales by Region (2023-2028) & (K Units)
Table 48. Global Paclitaxel Drug Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Paclitaxel Drug Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Paclitaxel Drug Sales by Type (2017-2022) & (K Units)
Table 51. Global Paclitaxel Drug Sales by Type (2023-2028) & (K Units)
Table 52. Global Paclitaxel Drug Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Paclitaxel Drug Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Paclitaxel Drug Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Paclitaxel Drug Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Paclitaxel Drug Sales by Application (2017-2022) & (K Units)
Table 57. Global Paclitaxel Drug Sales by Application (2023-2028) & (K Units)
Table 58. Global Paclitaxel Drug Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Paclitaxel Drug Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Paclitaxel Drug Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Paclitaxel Drug Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Paclitaxel Drug Sales by Country (2017-2022) & (K Units)
Table 63. North America Paclitaxel Drug Sales by Country (2023-2028) & (K Units)
Table 64. North America Paclitaxel Drug Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Paclitaxel Drug Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Paclitaxel Drug Sales by Type (2017-2022) & (K Units)
Table 67. North America Paclitaxel Drug Sales by Type (2023-2028) & (K Units)
Table 68. North America Paclitaxel Drug Sales by Application (2017-2022) & (K Units)
Table 69. North America Paclitaxel Drug Sales by Application (2023-2028) & (K Units)
Table 70. Europe Paclitaxel Drug Sales by Country (2017-2022) & (K Units)
Table 71. Europe Paclitaxel Drug Sales by Country (2023-2028) & (K Units)
Table 72. Europe Paclitaxel Drug Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Paclitaxel Drug Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Paclitaxel Drug Sales by Type (2017-2022) & (K Units)
Table 75. Europe Paclitaxel Drug Sales by Type (2023-2028) & (K Units)
Table 76. Europe Paclitaxel Drug Sales by Application (2017-2022) & (K Units)
Table 77. Europe Paclitaxel Drug Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Paclitaxel Drug Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Paclitaxel Drug Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Paclitaxel Drug Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Paclitaxel Drug Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Paclitaxel Drug Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Paclitaxel Drug Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Paclitaxel Drug Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Paclitaxel Drug Sales by Application (2023-2028) & (K Units)
Table 86. South America Paclitaxel Drug Sales by Country (2017-2022) & (K Units)
Table 87. South America Paclitaxel Drug Sales by Country (2023-2028) & (K Units)
Table 88. South America Paclitaxel Drug Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Paclitaxel Drug Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Paclitaxel Drug Sales by Type (2017-2022) & (K Units)
Table 91. South America Paclitaxel Drug Sales by Type (2023-2028) & (K Units)
Table 92. South America Paclitaxel Drug Sales by Application (2017-2022) & (K Units)
Table 93. South America Paclitaxel Drug Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Paclitaxel Drug Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Paclitaxel Drug Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Paclitaxel Drug Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Paclitaxel Drug Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Paclitaxel Drug Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Paclitaxel Drug Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Paclitaxel Drug Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Paclitaxel Drug Sales by Application (2023-2028) & (K Units)
Table 102. Paclitaxel Drug Raw Material
Table 103. Key Manufacturers of Paclitaxel Drug Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Paclitaxel Drug Typical Distributors
Table 107. Paclitaxel Drug Typical Customers
List of Figures
Figure 1. Paclitaxel Drug Picture
Figure 2. Global Paclitaxel Drug Revenue Market Share by Type in 2021
Figure 3. 30mg
Figure 4. 100mg
Figure 5. Global Paclitaxel Drug Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drugs Store
Figure 8. Global Paclitaxel Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Paclitaxel Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Paclitaxel Drug Sales (2017-2028) & (K Units)
Figure 11. Global Paclitaxel Drug Price (2017-2028) & (US$/Unit)
Figure 12. Global Paclitaxel Drug Production Capacity (2017-2028) & (K Units)
Figure 13. Global Paclitaxel Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Paclitaxel Drug Market Drivers
Figure 15. Paclitaxel Drug Market Restraints
Figure 16. Paclitaxel Drug Market Trends
Figure 17. Global Paclitaxel Drug Sales Market Share by Manufacturer in 2021
Figure 18. Global Paclitaxel Drug Revenue Market Share by Manufacturer in 2021
Figure 19. Paclitaxel Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Paclitaxel Drug Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Paclitaxel Drug Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Paclitaxel Drug Sales Market Share by Region (2017-2028)
Figure 23. Global Paclitaxel Drug Revenue Market Share by Region (2017-2028)
Figure 24. North America Paclitaxel Drug Revenue (2017-2028) & (USD Million)
Figure 25. Europe Paclitaxel Drug Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Paclitaxel Drug Revenue (2017-2028) & (USD Million)
Figure 27. South America Paclitaxel Drug Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Paclitaxel Drug Revenue (2017-2028) & (USD Million)
Figure 29. Global Paclitaxel Drug Sales Market Share by Type (2017-2028)
Figure 30. Global Paclitaxel Drug Revenue Market Share by Type (2017-2028)
Figure 31. Global Paclitaxel Drug Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Paclitaxel Drug Sales Market Share by Application (2017-2028)
Figure 33. Global Paclitaxel Drug Revenue Market Share by Application (2017-2028)
Figure 34. Global Paclitaxel Drug Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Paclitaxel Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Paclitaxel Drug Sales Market Share by Application (2017-2028)
Figure 37. North America Paclitaxel Drug Sales Market Share by Country (2017-2028)
Figure 38. North America Paclitaxel Drug Revenue Market Share by Country (2017-2028)
Figure 39. United States Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Paclitaxel Drug Sales Market Share by Type (2017-2028)
Figure 43. Europe Paclitaxel Drug Sales Market Share by Application (2017-2028)
Figure 44. Europe Paclitaxel Drug Sales Market Share by Country (2017-2028)
Figure 45. Europe Paclitaxel Drug Revenue Market Share by Country (2017-2028)
Figure 46. Germany Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Paclitaxel Drug Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Paclitaxel Drug Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Paclitaxel Drug Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Paclitaxel Drug Revenue Market Share by Region (2017-2028)
Figure 55. China Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Paclitaxel Drug Sales Market Share by Type (2017-2028)
Figure 62. South America Paclitaxel Drug Sales Market Share by Application (2017-2028)
Figure 63. South America Paclitaxel Drug Sales Market Share by Country (2017-2028)
Figure 64. South America Paclitaxel Drug Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Paclitaxel Drug Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Paclitaxel Drug Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Paclitaxel Drug Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Paclitaxel Drug Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Paclitaxel Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Paclitaxel Drug in 2021
Figure 76. Manufacturing Process Analysis of Paclitaxel Drug
Figure 77. Paclitaxel Drug Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のリポソームパクリタキセル市場2022年：市場規模予測（～2028年）
  • 世界のパクリタキセルAPI市場2022年：市場規模予測（～2028年）
  • 心臓用薬剤コーティングバルーンのグローバル市場展望 2023年-2029年：パクリタキセルコーティング型、その他コーティング型
  • PTA薬剤コーティングバルーンのグローバル市場展望 2023年-2029年：パクリタキセルコーティング、その他
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19506 )"世界のパクリタキセル薬物市場2022年：市場規模予測（～2028年）" (英文：Global Paclitaxel Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。